Annual Current Assets
$14.21 M
-$10.16 M-41.69%
31 December 2023
Summary:
Inhibikase Therapeutics annual total current assets is currently $14.21 million, with the most recent change of -$10.16 million (-41.69%) on 31 December 2023. During the last 3 years, it has fallen by -$571.70 thousand (-3.87%). IKT annual current assets is now -66.54% below its all-time high of $42.47 million, reached on 31 December 2021.IKT Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$4.19 M
-$4.41 M-51.29%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly total current assets is currently $4.19 million, with the most recent change of -$4.41 million (-51.29%) on 30 September 2024. Over the past year, it has dropped by -$13.36 million (-76.13%). IKT quarterly current assets is now -91.49% below its all-time high of $49.22 million, reached on 30 June 2021.IKT Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.7% | -76.1% |
| 3 y3 years | -3.9% | -90.9% |
| 5 y5 years | +1035.4% | - |
IKT Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -66.5% | at low | -90.9% | at low |
| 5 y | 5 years | -66.5% | >+9999.0% | -91.5% | >+9999.0% |
| alltime | all time | -66.5% | >+9999.0% | -91.5% | >+9999.0% |
Inhibikase Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.19 M(-51.3%) |
| June 2024 | - | $8.60 M(-20.4%) |
| Mar 2024 | - | $10.81 M(-23.9%) |
| Dec 2023 | $295.60 K(-47.7%) | $14.21 M(-19.0%) |
| Sept 2023 | - | $17.55 M(-20.2%) |
| June 2023 | - | $21.98 M(-20.4%) |
| Mar 2023 | - | $27.63 M(+13.4%) |
| Dec 2022 | $565.20 K | $24.37 M(-12.9%) |
| Sept 2022 | - | $27.99 M(-17.6%) |
| June 2022 | - | $33.95 M(-11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $38.39 M(-9.6%) |
| Dec 2021 | $0.00(0.0%) | $42.47 M(-7.4%) |
| Sept 2021 | - | $45.87 M(-6.8%) |
| June 2021 | - | $49.22 M(+314.6%) |
| Mar 2021 | - | $11.87 M(-19.7%) |
| Dec 2020 | $0.00(-100.0%) | $14.78 M(>+9900.0%) |
| Sept 2020 | - | $29.90 K(-1.3%) |
| June 2020 | - | $30.30 K(+12.2%) |
| Mar 2020 | - | $27.00 K(-23.7%) |
| Dec 2019 | $2900.00(-99.8%) | $35.40 K |
| Dec 2018 | $1.59 M | - |
FAQ
- What is Inhibikase Therapeutics annual total current assets?
- What is the all time high annual current assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual current assets year-on-year change?
- What is Inhibikase Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly current assets year-on-year change?
What is Inhibikase Therapeutics annual total current assets?
The current annual current assets of IKT is $14.21 M
What is the all time high annual current assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual total current assets is $42.47 M
What is Inhibikase Therapeutics annual current assets year-on-year change?
Over the past year, IKT annual total current assets has changed by -$10.16 M (-41.69%)
What is Inhibikase Therapeutics quarterly total current assets?
The current quarterly current assets of IKT is $4.19 M
What is the all time high quarterly current assets for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly total current assets is $49.22 M
What is Inhibikase Therapeutics quarterly current assets year-on-year change?
Over the past year, IKT quarterly total current assets has changed by -$13.36 M (-76.13%)